IMEP (chemotherapy)

IMEP is a chemotherapy regimen that is effective for nasal NK-/T-cell lymphoma.[1] This chemotherapy regimen was also tested in Hodgkin lymphoma as a part of a multidrug alternating scheme COPP/ABV/IMEP. But in that setting it showed no advantage in efficacy and toxicity compared to the use of ABVD or the alternating COPP/ABVD scheme.[2]

Drug regimen

DrugDoseModeDays
Ifosfamide1500 mg/m2 with mesnaIV infusionDays 1-3
Methotrexate30 mg/m2IV bolusDays 3 and 10
Etoposide100 mg/m2IV infusionDays 1-3
Prednisone120 mgPO qdDays 1-5

References

  1. ↑ "IMEP protocol in nasal NK/T-cell lymphoma". Retrieved 2014-09-11.{{cite web}}: CS1 maint: deprecated archival service (link)
  2. ↑ Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial[link removed]